Clark DJ - Search Results

1

An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers.

Zussman BD, Benincosa LJ, Webber DM, Clark DJ, Cowley H, Kelly J, Murdoch RD, Upward J, Wyld P, Port A, Fuder H. Zussman BD, et al. Among authors: clark dj. J Clin Pharmacol. 2001 Sep;41(9):950-8. doi: 10.1177/00912700122010924. J Clin Pharmacol. 2001. PMID: 11549099 Clinical Trial.

2

Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilast.

Zussman BD, Davie CC, Kelly J, Murdoch RD, Clark DJ, Schofield JP, Walls C, Birrell C, Webber D, Quinlan J, Ritchie SY, Carr A. Zussman BD, et al. Among authors: clark dj. Pharmacotherapy. 2001 Jun;21(6):653-60. doi: 10.1592/phco.21.7.653.34569. Pharmacotherapy. 2001. PMID: 11401178 Clinical Trial.

3

Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.

Zussman BD, Kelly J, Murdoch RD, Clark DJ, Mbchb, Schubert C, Collie H. Zussman BD, et al. Among authors: clark dj. Clin Ther. 2001 Jun;23(6):921-31. doi: 10.1016/s0149-2918(01)80079-5. Clin Ther. 2001. PMID: 11440291 Clinical Trial.

4

Warfarin pharmacodynamics unaffected by cilomilast.

Kelly J, Murdoch RD, Clark DJ, Webber DM, Fuder H. Kelly J, et al. Among authors: clark dj. Ann Pharmacother. 2001 Dec;35(12):1535-9. doi: 10.1345/aph.10369. Ann Pharmacother. 2001. PMID: 11793614 Clinical Trial.

5

Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.

Faessel HM, Smith BJ, Gibbs MA, Gobey JS, Clark DJ, Burstein AH. Faessel HM, et al. Among authors: clark dj. J Clin Pharmacol. 2006 Sep;46(9):991-8. doi: 10.1177/0091270006290669. J Clin Pharmacol. 2006. PMID: 16920893 Clinical Trial.

6

Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.

Faessel HM, Gibbs MA, Clark DJ, Rohrbacher K, Stolar M, Burstein AH. Faessel HM, et al. Among authors: clark dj. J Clin Pharmacol. 2006 Dec;46(12):1439-48. doi: 10.1177/0091270006292624. J Clin Pharmacol. 2006. PMID: 17101743 Clinical Trial.

7

Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers.

Burstein AH, Fullerton T, Clark DJ, Faessel HM. Burstein AH, et al. Among authors: clark dj. J Clin Pharmacol. 2006 Nov;46(11):1234-40. doi: 10.1177/0091270006291837. J Clin Pharmacol. 2006. PMID: 17050788 Clinical Trial.

8

The effect of food on the bioavailability of oral gemifloxacin in healthy volunteers.

Allen A, Bygate E, Clark D, Lewis A, Pay V. Allen A, et al. Int J Antimicrob Agents. 2000 Sep;16(1):45-50. doi: 10.1016/s0924-8579(00)00181-3. Int J Antimicrob Agents. 2000. PMID: 11185412 Clinical Trial.

9

Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study.

Feng B, Obach RS, Burstein AH, Clark DJ, de Morais SM, Faessel HM. Feng B, et al. Among authors: clark dj. Clin Pharmacol Ther. 2008 Apr;83(4):567-76. doi: 10.1038/sj.clpt.6100405. Epub 2007 Oct 31. Clin Pharmacol Ther. 2008. PMID: 17971819 Clinical Trial.

10

Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.

Wilson AM, Clark DJ, McFarlane L, Lipworth BJ. Wilson AM, et al. Among authors: clark dj. Eur J Clin Pharmacol. 1997;53(1):33-7. doi: 10.1007/s002280050333. Eur J Clin Pharmacol. 1997. PMID: 9349927 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters